ICD-10 Code C41.3: Malignant neoplasm of ribs, sternum and clavicle

Key Takeaways

ICD-10 Code C41.3 describes malignant neoplasm of ribs, sternum and clavicle, a billable primary bone cancer code effective October 1, 2025.

C41.3 applies to costal cartilage, costovertebral joint, and xiphoid process in addition to the named bones.

C41.3 codes primary bone malignancy only; metastatic bone disease uses C79.51, and confusing them causes claim denials and audit flags.

Pabau’s claims management software helps oncology and orthopedic practices apply C41.3 accurately and reduce coding errors at the point of documentation.

Most bone malignancy coding errors happen before the claim ever reaches the payer. A coder selects C41.3 for a patient with metastatic lung cancer that has spread to the ribs, the claim denies, and the audit trail reveals the wrong primary designation.

ICD-10 Code C41.3 is the correct code only when the ribs, sternum, or clavicle are the site of origin, not a metastatic target. The 2026 ICD-10-CM edition of this code became effective on October 1, 2025, and applies across oncology, orthopedic surgery, and inpatient reimbursement contexts.

This reference covers the applicable anatomical sites, excludes restrictions, MS-DRG mapping, and documentation requirements coders need to apply C41.3 correctly.

According to the WHO ICD-10 browser, C41.3 sits within the C40-C41 block for malignant neoplasms of bone and articular cartilage, specifically the “other and unspecified sites” category under C41. The US Clinical Modification version used under HIPAA-compliant clinical records adds site-specific detail through the ICD-10-CM tabular list.

ICD-10 Code C41.3: definition and billable status

C41.3 is a billable, specific ICD-10-CM code valid for reimbursement purposes in the 2026 edition. It describes a malignant neoplasm arising primarily in the ribs, sternum, or clavicle, including the associated cartilaginous and joint structures of the thoracic cage.

The code applies to primary malignancies documented as originating in the thoracic cage structures. Coders using dermatology EMR software for oncology-adjacent skin and soft-tissue cases should verify that the operative or pathology report identifies the listed structure as the primary site before selecting this code.

Applicable anatomical sites covered by C41.3

The ICD-10-CM tabular list extends C41.3 beyond the named bones to include adjacent structures under “Applicable To” inclusions. Coders unfamiliar with these inclusions often query unnecessary codes for the same anatomical region.

• Ribs: all ribs (true, false, floating)
• Sternum: the breastbone including the manubrium and body
• Clavicle: the collarbone
• Costal cartilage: the cartilage connecting ribs to the sternum
• Costovertebral joint: the joint between a rib and its corresponding vertebra
• Xiphoid process: the inferior projection of the sternum

All six structures above use C41.3 as the single billable code when the malignancy is primary. No additional specificity code exists within ICD-10-CM for laterality of ribs, so the coder documents the site detail in the medical record without appending a laterality modifier to the code itself.

Excludes notes for ICD-10 Code C41.3

The C41 category carries a single set of exclusion notes that restrict how C41.3 interacts with other codes. Getting these wrong can trigger a claim edit or an Excludes1 compliance flag during audit.

Excludes1 (hard exclusion)

An Excludes1 note means the excluded code and C41.3 can never be reported together for the same patient encounter. Category C41 carries an Excludes1 note directing six related presentations to other codes instead:

• Malignant neoplasm of bones of limbs (C40.-)
• Malignant neoplasm of cartilage of the ear (C49.0)
• Malignant neoplasm of cartilage of the eyelid (C49.0)
• Malignant neoplasm of cartilage of the larynx (C32.3)
• Malignant neoplasm of cartilage of the limbs (C40.-)
• Malignant neoplasm of cartilage of the nose (C30.0)

A chondrosarcoma documented as arising in nasal cartilage, for example, is never coded to C41.3 — it belongs under C30.0.

No Excludes2 note for C41

Category C41 does not carry an Excludes2 note. That means combinations like C41.3 with C79.51 (secondary malignant neoplasm of bone) are governed by clinical documentation and the primary-versus-secondary distinction covered earlier in this article, not by a formal excludes instruction.

A patient with a primary rib tumor (C41.3) who also has bone metastases from another site can still be coded with both C41.3 and C79.51 when the documentation supports both diagnoses — there is simply no excludes note dictating that combination either way.

C41.3 within the C40-C41 bone malignancy code block

C41.3 is one of five site-specific codes under C41. Understanding the sibling codes helps coders confirm they have the right code and not a near-miss neighbor. The same logic governs musculoskeletal codes elsewhere in ICD-10-CM — M45.9 distinguishes by spinal level rather than diagnosis alone.

C41.2 is the most common near-miss for C41.3. When a thoracic tumor involves the vertebral body adjacent to a rib, the coder must determine from the pathology report or operative note whether the primary site is the vertebra (C41.2) or the costovertebral joint (included under C41.3).

Primary vs secondary bone malignancy: choosing the right code

The single most consequential coding decision for bone malignancy is distinguishing primary from secondary disease. This distinction affects DRG assignment, reimbursement level, and cancer registry reporting. The oncology chapter applies the same requirement elsewhere, including C55, where confirmed primary-site documentation is what separates a billable code from a denial.

The ICD-10-CM Official Guidelines for Coding and Reporting state that when a malignancy is described as metastatic “to” a site, that site is the secondary location. When described as arising “in” or “of” a site, that site is primary. The word choice in the physician’s documentation drives the code assignment.

MS-DRG mapping for C41.3

For inpatient reimbursement, C41.3 maps to MS-DRG groupings under the CMS IPPS grouper. Verify specific DRG values against the current CMS IPPS grouper for the applicable fiscal year, as values update annually with each CMS rule. The CMS ICD-10-CM coding resources page publishes annual grouper files.

The presence or absence of a major complication or comorbidity (MCC/CC) in the inpatient record directly determines which DRG tier C41.3 maps to. Incomplete comorbidity documentation reduces reimbursement to the lower-weight DRG. Coders should query the attending physician when comorbidities appear in nursing or ancillary notes but are absent from the physician’s documented problem list.

Reduce coding errors and claim denials

Pabau's clinical documentation and claims management tools help oncology and orthopedic practices apply ICD-10 codes accurately from the point of care.

Book a demo

Documentation requirements for bone cancer coding

Accurate use of C41.3 depends on what the clinician documents, not on what the coder infers. Missing documentation elements are the root cause of most bone malignancy claim denials. Using structured medical documentation processes reduces the likelihood of submitting a code the clinical note cannot support.

• Primary site: the operative report, pathology report, or physician note must state that the rib, sternum, clavicle, or an included structure (costal cartilage, costovertebral joint, xiphoid process) is the site of origin
• Histologic type: document the tumor histology where available (osteosarcoma, chondrosarcoma, Ewing sarcoma); this supports medical necessity and cancer registry reporting
• Primary vs metastatic status: the note must clearly indicate whether the malignancy is primary or metastatic; vague language such as “bone lesion” or “malignant cells in bone” is insufficient
• Staging information: document TNM staging or equivalent when available; while not required for code assignment, it supports medical necessity review
• Comorbidities: document all active comorbidities explicitly in the physician note to support MCC/CC assignment for DRG optimization

Practices using clinical documentation software make it easier for physicians to record primary-site specificity at the point of care. Coders may not infer a primary site from imaging alone without physician confirmation.

Common coding errors and how to avoid them

Three patterns account for the majority of C41.3 coding errors in inpatient and outpatient claims. Addressing these at the point of documentation prevents denial cycles that take weeks to resolve. A billing compliance checklist built into the clinical workflow catches most of these before submission.

Error 1: assigning C41.3 to metastatic bone disease

This is the most common error. A patient with known breast cancer develops rib pain. Imaging shows a lytic rib lesion. The coder assigns C41.3 without checking whether the lesion is a metastasis.

The correct code is C79.51 (secondary malignant neoplasm of bone and bone marrow) plus the breast cancer code. C41.3 is reserved for tumors where the rib, sternum, or clavicle is documented as the site of origin.

Error 2: assigning C41.3 to malignancies the Excludes1 note routes elsewhere

The Excludes1 note above routes several related tumors away from C41.3, including malignant neoplasms of the limb bones and of cartilage in the ear, eyelid, larynx, and nose.

When documentation places the tumor in one of these structures, C41.3 is never the correct code, even if the site sits close to the thoracic cage. A sarcoma documented as arising in the cartilage of the larynx, for instance, is coded to C32.3, not C41.3.

Error 3: selecting C41.2 instead of C41.3 for costovertebral joint tumors

The costovertebral joint is included under C41.3, not C41.2 (vertebral column). When a tumor is documented as involving the costovertebral joint, select C41.3. If the tumor extends from the vertebral body into the joint, a clinical query to the attending physician clarifies the primary site and prevents an incorrect C41.2 assignment.

ICD-9-CM to ICD-10-CM crosswalk for C41.3

Practices migrating historical records or reconciling older claims against current coding need the ICD-9 equivalent. The General Equivalence Mappings (GEMs) published by CMS provide the forward and backward mappings. Confirm against the CDC/NCHS ICD-10-CM lookup tool for the most current mapping table.

The mapping from ICD-9-CM 170.3 to ICD-10-CM C41.3 is a one-to-one forward conversion. Practices that transitioned from ICD-9 to ICD-10 in October 2015 and retained legacy records coded under 170.3 can map those encounters directly to C41.3 for historical reporting purposes.

How Pabau supports accurate ICD-10-CM C41.3 coding

Oncology, orthopedic, and sports medicine practices using paper-based workflows or disconnected billing systems are most vulnerable to the C41.3 coding errors described above. The distance between what the clinician documents and what the coder sees on screen is where primary-vs-secondary errors occur most often.

Pabau’s claims management software brings the clinical note and the billing code into a single workflow. Coders can review structured documentation alongside the code assignment without toggling between systems, which reduces the errors that creep in when notes are transcribed hours or days after the encounter.

The platform’s AI-assisted clinical documentation tools help clinicians capture primary site specificity, histology, and comorbidity documentation during the encounter, not as an afterthought.

For practices managing patient data security alongside billing compliance, Pabau’s clinical documentation tools maintain a complete, timestamped audit trail for each encounter, supporting both payer audit responses and cancer registry submission workflows.

Conclusion

C41.3 coding errors consistently trace back to the same root cause: a clinician note that says “malignancy in the rib” without confirming whether that rib is the primary tumor site or a metastatic target. Resolving that ambiguity at the point of care, before the claim is submitted, is the most effective denial-prevention step available to coders.

Pabau’s integrated clinical documentation and claims management keeps the physician note and code assignment in the same workflow, preventing the documentation-to-billing mismatches where most C41.3 errors originate. To see how Pabau handles this for oncology and orthopedic practices, book a demo.

Continue your research

Coding a rib or extremity fracture instead of a malignancy? S82.61XN walks through a musculoskeletal fracture coding scenario.

Need the procedure-side counterpart for a chest wall excision? Review procedure code 11644 for malignant lesion excision billing.

Handling a musculoskeletal neck diagnosis in the same encounter? M43.6 covers torticollis coding requirements.

Documenting a related joint condition? M66.0 addresses popliteal cyst rupture coding.

Coding a craniofacial or skeletal deformity note? M95.2 covers acquired head deformity classification.

Frequently Asked Questions